PlaqueTec
PrivateLast Round
Early Funding
Apr 26, 2026
Total Funding Raised
$13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PlaqueTec operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was an Early Funding round in April 2026.
PlaqueTec is a medtech company that develops a proprietary intracoronary liquid biopsy system and data analysis platform to identify biomarkers for coronary artery disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PlaqueTec Comparables
Compare PlaqueTec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MONCYTE Health | 70% | |
| Thermo Fisher Scientific Inc. | 69% | |
| Multiomic Health | 64% |
For institutional investors. Book with your work email.
PlaqueTec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 26, 2026 | ||||
| Early Funding | Apr 30, 2024 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 26, 2026
Raised $5M in early funding.
- Apr 30, 2024
$8M raised, led by Future Fund UK Government and Baron Moynihan.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresSep 7, 2026
PlaqueTec Ltd. hires Diane as Chief Scientific Officer in 2018, where she oversees the scientific programme, including the BIOPATTERN clinical trial and BioCarta database.
For institutional investors. Book with your work email.
PlaqueTec Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PlaqueTec's valuation, stock price, and market status.
Is PlaqueTec a public or private company?
PlaqueTec is a private company.
What is the current stock price of PlaqueTec?
PlaqueTec is a private company, so its shares have no public market price. Caplight tracks PlaqueTec's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PlaqueTec worth (valuation)?
Valuation information for PlaqueTec is not publicly available.
Can I buy PlaqueTec stock?
PlaqueTec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PlaqueTec's last funding round?
PlaqueTec's most recent funding round was Early Funding on April 26, 2026.
Who are the main investors in PlaqueTec?
Investor information for PlaqueTec is not publicly disclosed.
Will PlaqueTec IPO soon?
No public IPO plans have been announced for PlaqueTec.
How can I track PlaqueTec secondary market activity?
Caplight tracks bids, offers, and trades in PlaqueTec's shares on secondary markets.